- Home
- GNTA
as 01-22-2025 10:37am EST
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.
| Founded: | 2014 | Country: | Italy |
| Employees: | N/A | City: | N/A |
| Market Cap: | 96.0M | IPO Year: | 2021 |
| Target Price: | $25.00 | AVG Volume (30 days): | 21.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.20 - $7.28 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Genenta Science S.p.A. News
GNTA Breaking Stock News: Dive into GNTA Ticker-Specific Updates for Smart Investing
Simply Wall St.
10 days ago
3 Penny Stocks In US With Market Caps Below $300M
TipRanks
12 days ago
Genenta Science announces amendment to pact with AGC Biologics
MT Newswires
13 days ago
Genenta Science Says Enhanced Partnership With AGC Biologics to Boost Cell Therapy Manufacturing
GlobeNewswire
13 days ago
Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing
PR Newswire
14 days ago
ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE
Simply Wall St.
2 months ago
3 US Penny Stocks With Market Caps Over $30M To Consider
GlobeNewswire
3 months ago
Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”
Simply Wall St.
3 months ago
Genenta Science S.p.A.'s (NASDAQ:GNTA) market cap rose US$46m last week; individual investors who hold 55% profited and so did insiders
Compare GNTA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GNTA Genenta Science S.p.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.